High throughput solubility measurement in drug discovery and development.

Measurement of drug solubility in various solvents is one of the key elements of compound characterization during the whole discovery and development process. This review summarizes current experimental approaches and addresses recent advances in the experimental methods used to determine drug solubility in drug discovery and early development. This paper focuses on high throughput methods designed to determine kinetic and thermodynamic (equilibrium) solubility but traditional methods are also presented. The focus, positioning, experimental setup, pros and cons, and limitations of individual assays are discussed and differences in solubility studies in discovery and development environments are highlighted. Finally, future needs and trends in solubility assay development designed to overcome current bottlenecks and trade-offs between speed and quality/quantity of measurements are addressed.

[1]  Li Di,et al.  Biological assay challenges from compound solubility: strategies for bioassay optimization. , 2006, Drug discovery today.

[2]  Neera Jain,et al.  Estimation of the aqueous solubility of weak electrolytes. , 2006, International journal of pharmaceutics.

[3]  Gary Eichenbaum,et al.  Screening method to identify preclinical liquid and semi-solid formulations for low solubility compounds: miniaturization and automation of solvent casting and dissolution testing. , 2007, Journal of pharmaceutical sciences.

[4]  S. Yalkowsky,et al.  Bilinear model for the prediction of drug solubility in ethanol/water mixtures. , 2005, Journal of pharmaceutical sciences.

[5]  Jochem Alsenz,et al.  Miniaturized Assay for Solubility and Residual Solid Screening (SORESOS) in Early Drug Development , 2007, Pharmaceutical Research.

[6]  P. Taboada,et al.  Effects of self-aggregation on the hydration of an amphiphilic antidepressant drug in different aqueous media , 2004 .

[7]  J. Legendre,et al.  Determination of the Aqueous Solubility of Drugs Using a Convenient 96-Well Plate-Based Assay , 2001, Drug development and industrial pharmacy.

[8]  Jérôme Hert,et al.  Comparison of Fingerprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures , 2004, J. Chem. Inf. Model..

[9]  Panos Macheras,et al.  A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. , 2006, International journal of pharmaceutics.

[10]  William Garvey.  Essentials of validation. Part II , 2006 .

[11]  M. Fujii,et al.  Effect of characteristics of compounds on maintenance of an amorphous state in solid dispersion with crospovidone. , 2007, Journal of pharmaceutical sciences.

[12]  Jef Adriaensen,et al.  Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early Drug Discovery. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  R. Löbenberg,et al.  Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.

[14]  B. Testa,et al.  Physicochemical profiling in drug research: a brief survey of the state-of-the-art of experimental techniques , 2002, Cellular and Molecular Life Sciences CMLS.

[15]  Y. Martin,et al.  A bioavailability score. , 2005, Journal of medicinal chemistry.

[16]  Michael J. Cima,et al.  Integration of an Opto-Mechanical Mass Sensor with a Powder- Dispensing Device for Microgram Sensitivity , 2004 .

[17]  S. Balbach,et al.  Pharmaceutical evaluation of early development candidates "the 100 mg-approach". , 2004, International journal of pharmaceutics.

[18]  Jennifer B Dressman,et al.  Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  Alex Avdeef,et al.  pH-Metric Solubility. 2: Correlation Between the Acid-Base Titration and the Saturation Shake-Flask Solubility-pH Methods , 2004, Pharmaceutical Research.

[20]  Abu T M Serajuddin,et al.  Trends in solubility of polymorphs. , 2005, Journal of pharmaceutical sciences.

[21]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[22]  A. Blasko,et al.  Revisiting the Solubility Concept of Pharmaceutical Compounds , 2001 .

[23]  Samuel H. Yalkowsky,et al.  A Simple Modified Absorption Potential , 2001, Pharmaceutical Research.

[24]  Thierry Lavé,et al.  Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[25]  P. Bummer,et al.  The Influence of Water Content of Triglyceride Oils on the Solubility of Steroids , 2005, Pharmaceutical Research.

[26]  R. Dewitte,et al.  Avoiding physicochemical artefacts in early ADME-Tox experiments. , 2006, Drug discovery today.

[27]  Bing Yan,et al.  Analysis and purification methods in combinatorial chemistry , 2004 .

[28]  Tudor I. Oprea.  Current trends in lead discovery: Are we looking for the appropriate properties? , 2002, J. Comput. Aided Mol. Des..

[29]  P. Carrupt,et al.  Experimental and virtual physicochemical and pharmacokinetic profiling of new chemical entities , 2005 .

[30]  T. Abribat,et al.  The rise and rise of drug delivery , 2005, Nature Reviews Drug Discovery.

[31]  Ping Gao,et al.  Enhanced Oral Bioavailability of a Poorly Water Soluble Drug PNU‐91325 by Supersaturatable Formulations , 2004, Drug development and industrial pharmacy.

[32]  I. Tetko,et al.  In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions. , 2006, Current medicinal chemistry.

[33]  Karen A. Dehring,et al.  Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility. , 2004, Journal of pharmaceutical and biomedical analysis.

[34]  Srini Venkatesh,et al.  Miniature Device for Aqueous and Non-aqueous Solubility Measurements During Drug Discovery , 2004, Pharmaceutical Research.

[35]  Vinod Nair,et al.  Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research. , 2004, Current drug metabolism.

[36]  B. Shoichet,et al.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.

[37]  Vinod P. Shah,et al.  Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions , 2002, Pharmaceutical Research.

[38]  Compound Transfer Efficiency from Polystyrene Surfaces: Application to Microarrayed Compound Screening , 2005, Journal of biomolecular screening.

[39]  B. Müller,et al.  Investigation of the influence of cosolvents and surfactants on the complexation of dexamethasone with hydroxypropyl-β-cyclodextrin by use of a simplex lattice design , 1993 .

[40]  Jianling Wang,et al.  The impact of early ADME profiling on drug discovery and development strategy , 2004 .

[41]  Kevin C. Johnson,et al.  Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption , 1996, Pharmaceutical Research.

[42]  C. Kibbey,et al.  An integrated process for measuring the physicochemical properties of drug candidates in a preclinical discovery environment. , 2001, Journal of pharmaceutical sciences.

[43]  Christel A. S. Bergström,et al.  Accuracy of calculated pH-dependent aqueous drug solubility. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[44]  E. Kerns,et al.  High throughput physicochemical profiling for drug discovery. , 2001, Journal of pharmaceutical sciences.

[45]  N. Medlicott,et al.  An in vitro kinetic method for detection of precipitation of poorly soluble drugs. , 2005, International journal of pharmaceutics.

[46]  Patrick Augustijns,et al.  Characterization of fasted‐state human intestinal fluids collected from duodenum and jejunum , 2006, The Journal of pharmacy and pharmacology.

[47]  Thilo A Fligge,et al.  Integration of a rapid automated solubility classification into early validation of hits obtained by high throughput screening. , 2006, Journal of pharmaceutical and biomedical analysis.

[48]  Li Di,et al.  Pharmaceutical profiling in drug discovery. , 2003, Drug discovery today.

[49]  Edward H. Kerns,et al.  Automation in Pharmaceutical Profiling , 2005 .

[50]  Lawrence X. Yu,et al.  In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome. , 2004, Current opinion in drug discovery & development.

[51]  Michael J. Cima,et al.  Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Ping Li,et al.  Solubilization of Fluasterone in cosolvent/cyclodextrin combinations. , 2003, International journal of pharmaceutics.

[53]  K. Box,et al.  Chasing equilibrium: measuring the intrinsic solubility of weak acids and bases. , 2005, Analytical chemistry.

[54]  Kenneth M Merz,et al.  Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships. , 2003, Journal of medicinal chemistry.

[55]  D. Igo,et al.  Development of an automated in-line microfiltration system coupled to an HPLC for the determination of solubility. , 2001, Journal of pharmaceutical and biomedical analysis.

[56]  S. Kazarian,et al.  Fourier transform infrared imaging for high-throughput analysis of pharmaceutical formulations. , 2005, Journal of combinatorial chemistry.

[57]  L. Di,et al.  Physicochemical profiling: overview of the screens. , 2004, Drug discovery today. Technologies.

[58]  S. Kazarian,et al.  High-throughput study of poly(ethylene glycol)/ibuprofen formulations under controlled environment using FTIR imaging. , 2006, Journal of combinatorial chemistry.

[59]  J. Dressman,et al.  Estimation of the Increase in Solubility of Drugs as a Function of Bile Salt Concentration , 2004, Pharmaceutical Research.

[60]  C. Lipinski.  Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[61]  G. Amidon,et al.  Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. , 2004, Molecular pharmaceutics.

[62]  Hans-Joachim Böhm,et al.  A guide to drug discovery: Hit and lead generation: beyond high-throughput screening , 2003, Nature Reviews Drug Discovery.

[63]  M. A. Holgado,et al.  Influence of crystallization solvent and dissolution behaviour for a diclofenac salt , 1995 .

[64]  Ping Li,et al.  Solubilization of flurbiprofen in pH-surfactant solutions. , 2003, Journal of pharmaceutical sciences.

[65]  J. Comer,et al.  Equilibrium versus kinetic measurements of aqueous solubility, and the ability of compounds to supersaturate in solution--a validation study. , 2006, Journal of pharmaceutical sciences.

[66]  C. Luscombe,et al.  Bile Salt/Lecithin Mixed Micelles Optimized for the Solubilization of a Poorly Soluble Steroid Molecule Using Statistical Experimental Design , 2003, Drug development and industrial pharmacy.

[67]  S. Frokjaer,et al.  Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[68]  Anette Müllertz,et al.  A Comparison of the Solubility of Danazol in Human and Simulated Gastrointestinal Fluids , 2000, Pharmaceutical Research.

[69]  W. Ostwald.  Studien über die Bildung und Umwandlung fester Körper , 1897 .

[70]  M. Gohel,et al.  Assessment of Similarity Factor Using Different Weighting Approaches , 2005 .

[71]  Christopher T. Walsh,et al.  Drugs as materials: valuing physical form in drug discovery , 2004, Nature Reviews Drug Discovery.

[72]  Mehran Yazdanian,et al.  The “High Solubility” Definition of the Current FDA Guidance on Biopharmaceutical Classification System May Be Too Strict for Acidic Drugs , 2004, Pharmaceutical Research.

[73]  Christel A. S. Bergström.  Computational and experimental models for the prediction of intestinal drug solubility and absorption. , 2003 .

[74]  V. H. Thomas,et al.  Development of a semi-automated chemical stability system to analyze solution based formulations in support of discovery candidate selection. , 2007, Journal of pharmaceutical and biomedical analysis.

[75]  Kiyohiko Sugano,et al.  High throughput solubility measurement with automated polarized light microscopy analysis. , 2006, Journal of pharmaceutical sciences.

[76]  Hilmar Weinmann,et al.  Automated Solubility Determination Using a Customized Robotic System and a Turbidity Probe , 2005 .

[77]  K. Valko,et al.  High-throughput physicochemical and in vitro ADMET screening , 2005 .

[78]  K. Thoma,et al.  Development of an automated flow-through dissolution system for poorly soluble drugs with poor chemical stability in dissolution media , 1998 .

[79]  Eric D. Carlson,et al.  Automated Integrated Forced Degradation and Drug-Excipient Compatibility Studies , 2005 .

[80]  Chris McNulty,et al.  A High-Throughput Combinatorial Approach for the Discovery of a Cremophor EL-Free Paclitaxel Formulation , 2003, Pharmaceutical Research.

[81]  D. Semin,et al.  A Novel Approach to Determine Water Content in DMSO for a Compound Collection Repository , 2005, Journal of biomolecular screening.

[82]  D. Yuan,et al.  Peak Seeker: An Algorithm for Rapid Determination of Solubility , 2005 .

[83]  S. Kazarian,et al.  ATR-FTIR spectroscopic imaging with expanded field of view to study formulations and dissolution. , 2006, Lab on a chip.

[84]  D. Grant,et al.  Analysis of the solubilization of steroids by bile salt micelles. , 1997, Journal of pharmaceutical sciences.

[85]  Christel A. S. Bergström,et al.  Computational models to predict aqueous drug solubility, permeability and intestinal absorption , 2005, Expert opinion on drug metabolism & toxicology.

[86]  C. Bevan,et al.  A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. , 2000, Analytical chemistry.

[87]  Matt Peterson,et al.  Application of high throughput technologies to drug substance and drug product development , 2004, Comput. Chem. Eng..

[88]  Aqueous Solubility in Discovery, Chemistry, and Assay Changes , 2004 .

[89]  Emily C. Ware,et al.  An Automated Approach to Salt Selection for New Unique Trazodone Salts , 2004, Pharmaceutical Research.

[90]  M. Kansy,et al.  Solubility-Excipient Classification Gradient Maps , 2007, Pharmaceutical Research.

[91]  J. Cheetham,et al.  An Automated Screening Assay for Determination of Aqueous Equilibrium Solubility Enabling SPR Study During Drug Lead Optimization , 2005 .

[92]  Lawrence X. Yu,et al.  A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. , 2006, Molecular pharmaceutics.

[93]  G. Amidon,et al.  Absorption potential: estimating the fraction absorbed for orally administered compounds. , 1985, Journal of pharmaceutical sciences.

[94]  S. Yalkowsky,et al.  Relationship between polysorbate 80 solubilization descriptors and octanol-water partition coefficients of drugs. , 2000, International journal of pharmaceutics.

[95]  Tycho Heimbach,et al.  Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds. , 2007, Journal of pharmaceutical and biomedical analysis.

[96]  J. Delaney.  Predicting aqueous solubility from structure. , 2005, Drug discovery today.

[97]  S. Yalkowsky,et al.  Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs. , 1999, Journal of pharmaceutical sciences.

[98]  J. Dressman,et al.  The BCS: Where Do We Go from Here? , 2001 .

[99]  B. Walther,et al.  Rapid assessment of drug metabolism in the drug discovery process. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[100]  L. Takahashi,et al.  Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility. , 2001, Journal of pharmaceutical sciences.

[101]  Jochem Alsenz,et al.  Development of a partially automated solubility screening (PASS) assay for early drug development. , 2007, Journal of pharmaceutical sciences.

[102]  J. S. Pedersen,et al.  Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds. , 2007, Journal of pharmaceutical sciences.

[103]  W. J. Lambert,et al.  Solubility of E2050 at various pH: a case in which apparent solubility is affected by the amount of excess solid. , 2002, Journal of pharmaceutical sciences.

[104]  S. Chemburkar,et al.  Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development , 2000 .

[105]  M. Machida,et al.  Biopharmaceutics Classification by High Throughput Solubility Assay and PAMPA , 2004, Drug development and industrial pharmacy.

[106]  S. Yalkowsky,et al.  Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants. , 1999, Journal of pharmaceutical sciences.

[107]  Jeffrey Millard,et al.  Solubilization by cosolvents. Establishing useful constants for the log-linear model. , 2002, International journal of pharmaceutics.

[108]  Hans Lennernäs,et al.  The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension , 2005, The Journal of pharmacy and pharmacology.

[109]  V. Alakhov,et al.  Combinatorial approaches to formulation development. , 2001, Current opinion in drug discovery & development.

[110]  Alex Avdeef,et al.  pH‐metric Solubility. 1. Solubility‐pH Profiles from Bjerrum Plots. Gibbs Buffer and pKa in the Solid State , 1998 .

[111]  T. Vilkner,et al.  Dry powder injection on chip. , 2005, Lab on a chip.

[112]  Mei-Ling Chen,et al.  Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunities. , 2004, Journal of pharmaceutical sciences.

[113]  S A Sundberg,et al.  High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. , 2000, Current opinion in biotechnology.

[114]  Robert S DeWitte,et al.  A hierarchical screening methodology for physicochemical/ADME/Tox profiling , 2006, Expert opinion on drug metabolism & toxicology.

[115]  Teng-Man Chen,et al.  Evaluation of a method for high throughput solubility determination using a multi-wavelength UV plate reader. , 2002, Combinatorial chemistry & high throughput screening.

[116]  David J W Grant,et al.  Identifying the Stable Polymorph Early in the Drug Discovery–Development Process , 2005, Pharmaceutical development and technology.

[117]  Ping Gao,et al.  Application of a Mixture Experimental Design in the Optimization of a Self‐Emulsifying Formulation with a High Drug Load , 2005, Pharmaceutical development and technology.

[118]  A. Glomme,et al.  Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. , 2005, Journal of pharmaceutical sciences.

[119]  T. Wiedmann,et al.  Examination of the solubilization of drugs by bile salt micelles. , 2002, Journal of pharmaceutical sciences.

[120]  J. Dressman,et al.  Comparison of the Adsorption of Several Drugs to Typical Filter Materials , 2005 .

[121]  A. Blackburn,et al.  Rapid, small-scale determination of organic solvent solubility using a thermogravimetric analyzer. , 2005, Journal of pharmaceutical and biomedical analysis.

[122]  Martin Kuentz,et al.  Drug-Excipient Compatibility Testing Using a High-Throughput Approach and Statistical Design , 2005, Pharmaceutical development and technology.

[123]  Tu Lee,et al.  Solubility, polymorphism, crystallinity, and crystal habit of acetaminophen and ibuprofen by initial solvent screening , 2006 .

[124]  Panos Macheras,et al.  Identification of Biowaivers Among Class II Drugs: Theoretical Justification and Practical Examples , 2004, Pharmaceutical Research.

[125]  W. Curatolo,et al.  Physical chemical properties of oral drug candidates in the discovery and exploratory development settings , 1998 .

[126]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[127]  Thorsteinn Loftsson,et al.  Self Association and Cyclodextrin Solubilization of NSAIDs , 2002 .

[128]  S. Venkatesh,et al.  Role of the development scientist in compound lead selection and optimization. , 2000, Journal of pharmaceutical sciences.

[129]  Kurt Scudder,et al.  High throughput sonication: evaluation for compound solubilization. , 2005, Combinatorial chemistry & high throughput screening.

[130]  A. Myerson,et al.  Development of a Small-Scale Automated Solubility Measurement Apparatus , 2005 .